Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy

BACKGROUND: We aimed to assess the efficacy and safety of erenumab, a fully human monoclonal antibody inhibiting the calcitonin gene-related peptide receptor (CGRPr), for the prevention of migraine in a real-life setting. MAIN BODY: We included in our observational study all patients with episodic o...

Descripción completa

Detalles Bibliográficos
Autores principales: Ornello, Raffaele, Casalena, Alfonsina, Frattale, Ilaria, Gabriele, Amleto, Affaitati, Giannapia, Giamberardino, Maria Adele, Assetta, Maurizio, Maddestra, Maurizio, Marzoli, Fabio, Viola, Stefano, Cerone, Davide, Marini, Carmine, Pistoia, Francesca, Sacco, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Milan 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137484/
https://www.ncbi.nlm.nih.gov/pubmed/32264820
http://dx.doi.org/10.1186/s10194-020-01102-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137484/
https://www.ncbi.nlm.nih.gov/pubmed/32264820
http://dx.doi.org/10.1186/s10194-020-01102-9

Ejemplares similares